Shandong Buchang Pharmaceuticals Co., Ltd.SSE: 603858

(603858)"Shandong Buchang Pharmaceuticals Co., Ltd."Announcement on the Profit Distribution Plan for the First Half of 2026

Oct 16, 2026 · Issued by Shandong Buchang Pharmaceuticals Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 603858 · Oct 16, 2026 · 2 pages · Chinese

Summary by 6ix AI

Shandong Buchang Pharmaceuticals Co., Ltd. has announced its profit distribution plan for the first half of the year. The company plans to distribute cash dividends to shareholders based on the total number of shares after excluding those held in a repurchase account. The distribution is designed to align with the company's operational model and long-term development goals.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/603858shandong-buchang-pharmaceuticals-co-ltdannouncement-on-the-profit-distribution-plan-for-the-first-half-of-2026

Shandong Buchang Pharmaceuticals Co., Ltd. on 6ix

Story so far

Announcement on 2025 Final Profit Distribution and Requesting the General Meeting of Shareholders to Authorize the Board of Directors to Prepare the 2026 Interim Dividend PlanApr 28, 2026

Earlier from Shandong Buchang Pharmaceuticals

Later from Shandong Buchang Pharmaceuticals

(603858)"Shandong Buchang Pharmaceuticals Co., Ltd."Announcement on Approval of Marketing Authorization for Qianlie Shutong Capsules in IndonesiaOct 21

All Shandong Buchang Pharmaceuticals news releases

Follow Shandong Buchang Pharmaceuticals into a list and get an email when it puts out news.

Follow Shandong Buchang Pharmaceuticals